Related Experiment Video
Updated: Jun 27, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy
Nobuhiro Dougu1, Shuji Joho, Lishen Shan
1Department of Neurology, Toyama University Hospital, Toyama University Hospital, Toyama, Japan.
Abstract:
Danon disease is an X-linked dominant multisystem disorder that includes hypertrophic cardiomyopathy with skeletal myopathy, and results from mutations in the gene encoding the lysosome-associated membrane protein-2 (LAMP-2). To date, over 20 different mutations in LAMP2 have been identified. Three members of a family, a male proband (18 years old) and 2 sisters (15 and 20 years old) were studied. Their mother had been diagnosed with dilated cardiomyopathy at the age of 39 years, and died from advanced heart failure at the age of 43 years. The proband developed marked concentric hypertrophy at the age of 5 years and DNA analyses revealed a novel hemizygous frameshift mutation (c.573delA) in exon 5. The 2 affected sisters were also heterozygous for the same mutation. Functional analyses of this novel LAMP2 mutation are mandatory.
Insights
Danon disease, a genetic disorder affecting the heart and muscles, is caused by LAMP2 gene mutations. This study identifies a novel mutation in a family, highlighting the need for further functional analysis.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Danon disease is an X-linked dominant disorder impacting multiple organ systems.
- It is characterized by hypertrophic cardiomyopathy and skeletal myopathy.
- Mutations in the lysosome-associated membrane protein-2 (LAMP2) gene are the underlying cause, with over 20 identified to date.
Observation:
- A family with three affected members (18-year-old male proband, 15 and 20-year-old sisters) was studied.
- The proband exhibited concentric hypertrophy from age 5.
- The mother had dilated cardiomyopathy and died from heart failure.
Findings:
- DNA analysis revealed a novel hemizygous frameshift mutation (c.573delA) in exon 5 of the LAMP2 gene in the male proband.
- The two affected sisters were heterozygous for the same LAMP2 mutation.
- This represents a new genetic variant contributing to Danon disease.
Implications:
- Identification of a novel LAMP2 mutation provides further insight into the genetic landscape of Danon disease.
- Functional studies are essential to understand the pathogenicity of this specific mutation.
- This research underscores the importance of genetic diagnostics in multisystem disorders like Danon disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care

